Atea Pharmaceuticals (AVIR) Prepaid Assets (2019 - 2026)
Atea Pharmaceuticals' (AVIR) quarterly Prepaid Assets came in at $7.2 million in Q1 2026, down 13.07% year-on-year from $8.3 million in Q1 2025, and down 21.5% quarter-over-quarter from $9.2 million in Q4 2025.
Atea Pharmaceuticals (AVIR) Prepaid Assets (2019 - 2026) Analysis & Trends
Atea Pharmaceuticals' Prepaid Assets history runs 8 years deep, the most recent figure standing at $7.2 million for Q1 2026.
- On a quarterly basis, Prepaid Assets fell 13.07% year-over-year to $7.2 million in Q1 2026; TTM through Mar 2026 was $7.2 million, a 13.07% decrease from a year earlier, with the FY2025 full-year figure at $9.2 million, up 20.0% from the prior year.
- Prepaid Assets declined to $7.2 million in Q1 2026 per AVIR's latest filing, from $9.2 million in the prior quarter.
- Across five years, Prepaid Assets topped out at $14.2 million in Q4 2022 and bottomed at $4.1 million in Q3 2024.
- The 5-year median for Prepaid Assets is $7.7 million (2022), against an average of $8.5 million.
- Across the five-year window, Prepaid Assets surged 278.76% in 2022 and plunged 67.45% in 2024, its largest moves.
- Year by year, Prepaid Assets stood at $14.2 million in 2022, then decreased by 13.11% to $12.3 million in 2023, then tumbled by 38.18% to $7.6 million in 2024, then increased by 20.0% to $9.2 million in 2025, then declined by 21.5% to $7.2 million in 2026.
- Per Business Quant, the three latest AVIR Prepaid Assets figures stand at $7.2 million (Q1 2026), $9.2 million (Q4 2025), and $6.8 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Atea Pharmaceuticals | 376.19 Mn | 376.19 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 7.19 Mn |
| Dec 31, 2025 | 9.16 Mn |
| Sep 30, 2025 | 6.83 Mn |
| Jun 30, 2025 | 5.89 Mn |
| Mar 31, 2025 | 8.27 Mn |
| Dec 31, 2024 | 7.63 Mn |
| Sep 30, 2024 | 4.09 Mn |
| Jun 30, 2024 | 4.16 Mn |
| Mar 31, 2024 | 7.27 Mn |
| Dec 31, 2023 | 12.35 Mn |
| Sep 30, 2023 | 8.19 Mn |
| Jun 30, 2023 | 12.76 Mn |
| Mar 31, 2023 | 11.90 Mn |
| Dec 31, 2022 | 14.21 Mn |
| Sep 30, 2022 | 12.45 Mn |
| Jun 30, 2022 | 4.97 Mn |
| Mar 31, 2022 | 7.69 Mn |
| Dec 31, 2021 | 8.03 Mn |
| Sep 30, 2021 | 3.29 Mn |
| Jun 30, 2021 | 4.65 Mn |